VISK — Viskase Holdings, Inc.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 727510 ·
Last close
$4.43
Market Cap
$63.49M
52W High
$8.55
52W Low
$0.02
ADV30
937
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 95,279,000 | 8,503,000 | -2,848,000 | -6,403,000 | 427,470,000 | 7,747,000 | 250,150,000 |
| Mar 2026 | 86,537,000 | 9,000,000 | -3,970,000 | -6,689,000 | 428,874,000 | 28,619,000 | 238,190,000 |
| Dec 2025 | 81,727,000 | 4,850,000 | -9,879,000 | -18,679,000 | 402,142,000 | 9,217,000 | 257,782,000 |
| Sep 2025 | 91,162,000 | 5,865,000 | -8,055,000 | -12,984,000 | 399,836,000 | 7,692,000 | 250,521,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,446,000
Investing CF
$-36,997,000
Financing CF
$63,347,000
CapEx
$-36,997,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-7.43
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-30,035,000
Inventory
$100,337,000
Receivables
$69,981,000
ST Investments
—
EBIT TTM
$-35,149,000
Pretax Income TTM
$-45,063,000
Interest Exp TTM
$9,914,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$353,673,984
EBITDA
$-1,512,000
Free Cash Flow
$-32,188,376
Enterprise Value
$206,461,392
Total Cash
$7,747,000
Total Debt
$154,923,008
Shares Out
14,331,620
Trailing EPS
$-2.59
Book Value
$12.49
ROE
-22.7%
ROA
-2.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 364,356,000 | -17,268,000 | -65,494,000 | 402,142,000 | 257,782,000 | 145,843,000 | 12,998,000 |
| Dec 2024 | 403,775,000 | 17,800,000 | -5,360,000 | — | — | — | 3,369,000 |
| Dec 2023 | 445,984,000 | 39,721,000 | 13,506,000 | — | — | — | 44,165,000 |
TTM Snapshot
Revenues TTM
$176,668,000
NetIncome TTM
$-13,646,000
OpCashFlow TTM
—
Assets (Latest)
$424,483,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CSBR | CHAMPIONS ONCOLOGY, INC. | $63.91M | $4.59 | — |
| NMRA | Neumora Therapeutics, Inc. | $62.85M | $0.33 | — |
| CRDF | Cardiff Oncology, Inc. | $65.85M | $0.85 | — |
| ATRA | Atara Biotherapeutics, Inc. | $66.22M | $6.50 | — |
| CGTX | COGNITION THERAPEUTICS INC | $59.90M | $0.63 | — |
Recent Insider Activity
No insider activity indexed for this ticker.